CHR. HANSEN A/S: Financial statements 2016
CVR: 12516479
Source: annual report 2016, Danish Business Authority
01/09/2015 – 31/08/2016
CHR. HANSEN A/S (CVR 12516479) has filed annual accounts for 2016. In 2016, the company reported revenue of DKK 4,803,528,000 and a net result of DKK 1,140,262,000 compared with DKK 1,064,163,000 the year before. That is an increase of 13% compared with the year before. The profit margin was 23.7%. Equity in the 2016 report amounted to DKK 2,630,744,000. The solvency ratio was 50.8%.
- Revenue
- DKK 4,803,528,000
- Gross Profit
- DKK 2,387,081,000
- Profit/Loss
- DKK 1,140,262,000
- Equity
- DKK 2,630,744,000
- Total Assets
- DKK 5,183,335,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | 4.8B | 2.4B | 1.1B | 2.6B | - |
| 2015 | 4.3B | 2.2B | 1.1B | 1.4B | - |
| 2014 | 3.7B | 2B | 911.5M | 1.7B | - |
| 2013 | 3.7B | 2B | 892.9M | 1.1B | - |
Official annual report
Find more companies like CHR. HANSEN A/S
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2016
As of September 1, 2016, Alice Hjørdis Larsen is registered as director of CHR. HANSEN A/S.
About CHR. HANSEN A/S
CHR. HANSEN A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 1988. The company is registered under the industry Fremstilling af andre kemiske produkter i.a.n.. The company was previously named CHR. HANSEN'S LABORATORIUM DANMARK A/S and A/S PSE NR. 2770. The management consists of Morten Enggaard Rasmussen. The board consists of Rainer Chapour Lehmann (chair), Anders Lund, Helle Rexen and Lisbet Kragelund. The company is owned by NOVOZYMES A/S. The company has 1,747 employees (2026). In 2025, the company reported revenue of DKK 6,820,616,000 and a net result of DKK 2,105,477,000 compared with DKK 1,891,419,000 the year before. Equity in the 2025 report amounted to DKK 11,263,718,000.